ArticleFrontiers in immunology2026

A dual-action humanized DKK-1 antibody that activates the Wnt/β-catenin signaling pathway and inhibits the RANKL signaling pathway for osteoporosis therapy.

Sheng Hou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.